Auction-Rate Securities Rights Agreement



 Exhibit 10.29 
  

			
	

	  	 UBS Financial Services Inc.
 1200 Harbor
Boulevard
 Weehawken, NJ 07086

		
		  	 James M. Pierce
 Co-Head

		  	Wealth Management Advisor Group US
		  	
	 ENDO PHARMACEUTICALS INC.
	  	James D. Price
	 C/O MARK BRADLEY
	  	Co-Head
	 100 ENDO BOULEVARD
 CHADDS FORD PA 19317-9666
	  	Wealth Management Advisor Group US
		  	www.ubs.com
		
		  	October 8, 2008
		
		  	 Branch Telephone Number
 +1-312-525-4500

		
		  	Account Number: CP 06464

 We are pleased to offer you a way to liquidate certain of your auction rate securities (ARS). UBS has designed a
solution that gives you the option to hold your ARS or sell the securities back to UBS. This solution is available for ARS that were held in a UBS account on February 13, 2008, and that are not successfully clearing at auction (Eligible ARS).

 UBS is offering you “Auction Rate Securities Rights” (Rights) to sell Eligible ARS at par value to UBS at any time during a two-year time
period. These Rights are nontransferable securities registered with the U.S. Securities and Exchange Commission (SEC). This is a limited time offer that will expire on November 14, 2008, Accepting this offer may impact your legal rights. Not
accepting this offer may have repercussions on outstanding loans secured by Eligible ARS. As a result, it is important that you review the prospectus carefully. 
 The key features and terms of the offer are summarized below. For complete details, please see the enclosed prospectus. 
  

	•	 	 UBS is offering you nontransferable Rights to sell Eligible ARS, held in the UBS account identified above, at par value to UBS at any time during the period of
June 30, 2010, through July 2, 2012. 


  

	 	•	 	 You may instruct your UBS Financial Advisor to exercise these Rights at any time during this time period; 


  

	 	•	 	 If you do not exercise your Rights, the Eligible ARS will continue to accrue interest or dividends as determined by the auction process;



  

	 	•	 	 If you do not exercise your Rights before July 2, 2012, they will expire and UBS will have no further obligation to buy your Eligible ARS.



  

	•	 	 Clients who accept this offer give UBS the discretion to purchase or sell their Eligible ARS at any time after accepting the firm’s offer and without other
prior notice. 


  

	 	•	 	 UBS will purchase tax-exempt Auction Preferred Stock (a specific type of ARS also known as APS) at any time after clients accept the firm’s Rights offer;



  

	 	•	 	 UBS will only exercise its discretion to purchase or sell Eligible ARS for the purpose of restructurings, dispositions or other solutions that will provide clients
with par value for their Eligible ARS; 


  

	 	•	 	 In purchasing Eligible ARS or selling Eligible ARS on behalf of clients, including tax-exempt APS, UBS will act in its capacity as broker-dealer and will execute
these transactions on a principal basis regardless of the type of client accounts in which the Eligible ARS are held. Please see pages 27-28 in the enclosed prospectus for more information; 


  

	 	•	 	 UBS will pay clients par value for their Eligible ARS within one day of settlement of the transaction; 


  

	 	•	 	 Eligible ARS are subject to issuer redemptions at any time. 


 UBS AG has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you make an investment decision, you should read the prospectus in that registration statement and
other documents that UBS has filed with the SEC for more complete information about UBS and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov or by calling UBS’s ARS Client Service
Center at +l-800-253-1974. 
  

			
	 UBS Financial Services Inc. and UBS International Inc. are subsidiaries of UBS AG.
	  	1C-ARS0








 UBS Financial Services Inc. 
 

 
  

	•	 	 Clients who accept this offer release UBS and its employees/agents from all claims except claims for consequential damages directly or indirectly relating to its
marketing and sale of ARS and expressly agree not to seek any damages or costs (punitive damages, attorney fees, etc.) other than consequential damages. Clients also will not serve as a class representative or receive benefits under any class action
settlement or investor fund. 


  

	•	 	 UBS will provide clients who accept the offer “no net cost” loans up to the par value of Eligible ARS until June 30, 2010. Please see pages 36-39 in
the enclosed prospectus for more information. 


  

	•	 	 UBS will reimburse all clients who participated in prior UBS ARS loan programs after February 13, 2008, for the difference between the cost of the loan and the
applicable interest paid on the Eligible ARS. 


 THIS OFFER EXPIRES ON NOVEMBER 14, 2008. Please complete, sign and date the
enclosed form and return it in the postage-paid envelope if you wish to accept this offer. We must receive your signed acceptance form no later than November 14, 2008. 
 You may receive multiple letters from us depending on the type of ARS you own or if you have ARS in multiple accounts. Please note you must return a form for each letter you receive to accept all
available offers relating to your ARS holdings. Please read each response form carefully as the terms may vary. 
 A list of your Eligible ARS in the
account identified on the first page of this letter is attached. Additional information about your Eligible ARS, including the most recent interest rates and dividend yields, is available at www.ubs.com/auctionratesecurities. 
 If you have any questions about your Eligible ARS or this offer, please contact your UBS Financial Advisor or Branch Manager at the telephone number listed at the top of
this letter. Please note that UBS Financial Advisors and Branch Managers cannot provide legal or tax advice regarding this offer. Instructions to exercise your Rights should be directed to your UBS Financial Advisor or Branch Manager. 
 We regret any hardship that the failure of the ARS markets may have caused you. We hope that the offer described above and discussed in detail in the prospectus provides
resolution for you regarding this matter. We look forward to continuing our relationship with you and to serving your future investment needs. 
 Thank you
for your business and for maintaining your relationship with UBS. 
  

					
	Sincerely,	 		 	
			
	

	 	

	 	
	James M. Pierce	 	James D. Price	 	

 UBS Financial Services Inc. serves as the clearing firm for UBS International Inc. Accordingly the information and
terms contained in this letter and the accompanying materials are directed to clients of both UBS Financial Services Inc and UBS International Inc. 
  

			
	UBS Financial Services Inc. and UBS International Inc. are subsidiaries of UBS AG.	  	1C-ARS0








 Current rate and dividend information 
 To allow you to view the current interest rates and/or dividends your holdings are earning, we have created an online tool available at www.ubs.com/auctionratesecuritses, 
 Simply enter the nine-digit CUSIP number(s) shown below to obtain the most current information about your securities. 
 Percentages displayed in the descriptions below are as of September 30, 2008. 
  

											
	 CUSIP
	  	 DESCRIPTION
	  	 CUSIP
	  	 DESCRIPTION
	  	 CUSIP
	  	 DESCRIPTION

	 00432MAC3
	  	 ACCESS TO LNS LRNG STUDT
 LN CORP CA AMT REV BE/R/

 VARIABLE RATE
 RATE 11.940% MATURES 07/01/35

	  	00432MAX7	  	 ACCS TO LNS FOR LRNG SDT
 CA SER IV-A RV AMT BE/R/

 VARIABLE RATE
 RATE 11.940% MATURES 07/01/37
	  	010305EU0	  	 ALABAMA HGHR ED LN CORP
 SER A-1 B/E
/R/
 VARATE PUTBND
 RATE 09.765% MATURES
03/01/33

						
	 010305EV8
	  	 ALABAMA HGHR ED LN CORP
 SER A-2 B/E
/R/
 VARATE PUTBND
 RATE 03.220% MATURES 11/01/41

	  	011855AA1	  	 ALASKA STUDNT LN CRP ED
 AMT RV ARC SER A BE /R/

 VARIABLE RATE
 RATE 03.483% MATURES 06/01/37
	  	155488BV0	  	 CENTRAL TEXAS HGHR ED AU
 SER 2002A REV AMT B/E
/R/
 VARIABLE RATE
 RATE 12.000% MATURES
12/01/36

						
	 429825AM4
	  	 NEW JRSY HGR ED STU AMT
 ARCS SER 01A RV MBIAB/R/

 VARIABLE RATE
 RATE 03.378% MATURES 06/01/36

	  	455900AQ3	  	 INDIANA SECNDRY MRKT EDU
 AMT ARCS 031 RV AMTBE/R/

 VARIABLE RATE
 RATE 14.000% MATURES 12/01/38
	  	462590FG0	  	 IA STUD LN LIQUIDTY CORP
 ARC W RV AMBAC AMT BE/R/

 VARIABLE RATE
 RATE 03.378% MATURES
12/01/37

						
	 462590GJ3
	  	 IOWA STUD LN LIQ REV
 SER D AMBAC AMT
BE/R/
 VARIABLE RATE
 RATE 14.000% MATURES 12/01/41
	  	49130NAV1	  	 KENTUCKY HIGHER ED STUD
 LN ARC REV AMT B/E /R/

 VARIABLE RATE
 RATE 08.540% MATURES 06/01/34
	  	49130NAW9	  	 KENTUCKY HIGHER ED STUD
 LN REV ARC SER A REV /R/

 VARIABLE RATE
 RATE 12.000% MATURES
06/01/34

						
	 4913ONBB4
	  	 KENTUCKY HIGHER ED STUD
 LN REV A-1 AMT B/E /R/

 VARIABLE RATE
 RATE 09.940% MATURES 06/01/35

	  	49926CAC5	  	 KNOWLEDGEFUNDING OH INC
 OHIO STUD LN RV
/R/
 VARIABLE RATE
 RATE 03.220% MATURES 12/01/40
	  	49926CAG6	  	 KNOWLEDGEFUNDING OH INC
 OHIO S/L RV A3 B/E /R/

 VARIABLE RATE
 RATE 03.133% MATURES
12/01/41

						
	 57563REE5
	  	 MA ED FIN AU ISS 2002 RV
 ISSUE SER D AMBAC BE/R/

 VARIABLE RATE
 RATE 08.540% MATURES 01/01/37

	  	594520KL1	  	 MICHIGAN HIGHER ED STUD
 LN AU RF AMT
BE/R/
 VARIABLE RATE
 RATE 06.878% MATURES
03/01/40
	  	606072GK6	  	 MISSOURI HGR ED LN AUTH
 ARC SER C REV AMT B/E/R/

 VARIABLE RATE
 RATE 03.483% MATURES
01/15/32

						
	 644614CV9
	  	 NEW HAMPSHIRE HLTH & EDU
 SER A REV AMT B/E
/R/
 VARIABLE RATE
 RATE 10.203% MATURES 12/01/35

	  	644614HG7	  	 NEW HAMPSHIRE HLTH & EDU
 35 DAY SER A-1 REV
/R/
 VARIABLE RATE
 RATE 06.878% MATURES 12/01/38
	  	644614PC7	  	 NEW HAMPSHIRE HLTH & EDU
 T/E SER 06A-1 AMT
B/E /R/
 VARIABLE RATE
 RATE 03.115% MATURES
12/01/40

						
	 6446145J9
	  	 NEW HAMPSHIRE HLTH & EDU
 SER A REV B/E /R/

 VARIABLE RATE
 RATE 11.725% MATURES 12/01/41

	  	646080GZ8	  	 NEW JERSY ST HGHR ED
 SER B MBIA AMT B/E
/R/
 VARIABLE RATE
 RATE 06.878% MATURES 12/01/40
	  	67759LAF2	  	 OHIO ST STUDENT LN REV
 SER A RV AMBAC AMT BE/R/

 VARIABLE RATE
 RATE 03.115% MATURES
09/01/41

						
	 709163CW7
	  	 PA ST H/E ASST AGY REV
 STUD LN ARCS SER P-1 /R/

 VARIABLE RATE
 RATE 08.540% MATURES 03/01/22

	  	709163CX5	  	 PA ST H/E ASST AGY REV
 S/L ARCS P2 AMT B/E /R/

 VARIABLE RATE
 RATE 14.000% MATURES 03/01/22
	  	709163EC9	  	 PA ST H/E ASST AGY REV
 SET AA-2 REV STUDE /R/

 VARIABLE RATE
 RATE 08.540% MATURES
06/01/39

						
	 709163ED7
	  	 PA ST H/E ASST AGY REV
 SER AA-3 STUDE B/E /R/

 VARIABLE RATE
 RATE 14.000% MATURES 06/01/39

	  	762315EM7	  	 RHODE ISLAND ST STUD LN
 SER 2 RV AMBAC AMT BE/R/

 VARIABLE RATE
 RATE 06.878% MATURES 12/01/34
	  	813659AM1	  	 HAWAII SECOND MKT SERV
 T/E 35 DAY ARC AMT BE/R/

 VARIABLE RATE
 RATE 06.615% MATURES
03/01/40

						
	 917546ES8
	  	 UTAH ST BRD OF REGT
 SER G REV AMT B/E
/R/
 VARIABLE RATE
 RATE 08.540% MATURES 05/01/33

	  	917546FR9	  	 UTAH ST BRD OF REGT
 SERV-1 REV AMT B/E
/R/
 VARIABLE RATE
 RATE 13.738% MATURES 11/01/36
	  	917546FVO	  	 UTAH ST BRD OF REGT
 SER Y-1-C REV AMT
B/E/R/
 VARIABLE RATE
 RATE 13.738% MATURES
11/01/37

						
	 917546FZ1
	  	 UTAH ST BRD OF REGT ARC
 35DAY KL REV AMT B/E/R/

 VARIABLE RATE
 RATE 13.738% MATURES 11/01/38

	  	92428CDC5	  	 VERMONT STUDENT ASSIST
 CORP SER 1995B REV /R/

 VARIABLE RATE
 RATE 06.878% MATURES 12/15/25
	  		  	








 ©2008 UBS Finanical Services Inc. All rights reserved. Member SIPC. 
 www.ubs.com/financialservicesinc 
 080826-2033-Let/CUSIP 
  

			
	UBS Financial Services Inc. is a subsidiary of UBS AG.	  	1C-ARS0








 UBS Financial Services Inc. 
 

 
 Please complete and sign this form. 
 We must receive it by November 14, 2008. 
 Acceptance of UBS’s offer relating to auction rate securities 
 By signing below and returning this form, I accept UBS’s offer of Rights relating to my Eligible ARS in the account listed below. I understand and acknowledge the
following: 
  

	 	•	 	 All Eligible ARS must remain in my UBS account listed below until I exercise my Rights to sell my Eligible ARS to UBS or they are redeemed by the issuer or
purchased or sold on my behalf by UBS; 


  

	 	•	 	 I will instruct my UBS Financial Advisor or Branch Manager if and when I want to exercise my Rights and sell my Eligible ARS to UBS during the period of
June 30, 2010, through July 2, 2012; 


  

	 	•	 	 The acceptance of UBS’s offer constitutes consent (to the extent legally required) for UBS, acting as principal, to purchase my Eligible ARS or to sell them on
my behalf at any time in its sole discretion and without other prior notice to me, from the date that I accept this offer through July 2, 2012; 


  

	 	•	 	 If UBS purchases, sells or otherwise disposes of my Eligible ARS, it will deposit the par value in my account within one business day of settlement of the
transaction; 


  

	 	•	 	 I release UBS and its employees/agents from all claims except claims for consequential damages directly or indirectly relating to its marketing and sale of ARS and
expressly agree that I will not seek any damages or costs (punitive damages, attorney fees, etc.) other than consequential damages. I also will not serve as a class representative or receive benefits under any class action settlement or investor
fund; 


  

	 	•	 	 if the account named below is in the name of a corporation, partnership, trust or other entity, I represent and warrant that I have the power and authority to
accept this offer on behalf of that entity. 


  

					
	 	 	 	  	 Please complete and sign this form.
 We must
receive it by November 14, 2008.

			
		 	 ENDO PHARMACEUTICALS INC.
 C/O MARK BRADLEY
 100 ENDO BOULEVARD
 CHADDS FORD PA 19317-9666
	  	 Mail         UBS Financial Services Inc.
                   ATTN: ARS
Group
                   1000 Harbor Boulevard
                   Weehawken, NJ 07086

			
		 	 Account Number: CP 06464
	  	 Fax           +1-201-442-7766


  

									
	

	 	Account owner signature 	  	/s/ David P. Holveck	  	    Date	  	11/10/09
		 		  	David P. Holveck, President & CEO	  		  	
					
		 	Additional party signature 	  	 	  	    Date 	  	 
					
		 	Daytime telephone number 	  	610-558-9800 x 4123	  		  	

 If you have questions, please contact your UBS Financial Advisor or Branch Manager at +1-312-525-4500. 

Clients outside the U.S. may call +1-201-352-0105 collect. 
 We kindly
request that you do not include comments or questions on this form as it could delay processing of your instructions. 
 UBS AG has filed a registration
statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you make an investment decision, you should read the prospectus in that registration statement and other documents that UBS has filed with
the SEC for more complete information about UBS and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov or by calling UBS’s ARS Client Service Center at +1-800-253-1974. 
 UBS Financial Services Inc. serves as the clearing firm for UBS international Inc. Accordingly, the information and terms contained in this letter and the accompanying
materials are directed to clients of both UBS Financial Services Inc and UBS International Inc. 
  

			
	©2008 UBS Financial Services Inc. All rights reserved. Member SIPC.	  	1C-ARS0

 

 
 000464